Canada markets closed

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.3200-0.9700 (-22.61%)
At close: 04:00PM EDT
3.3400 +0.02 (+0.60%)
After hours: 07:57PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts4455
Avg. Estimate-0.51-0.49-2.3-1.06
Low Estimate-0.56-0.54-3.24-1.22
High Estimate-0.46-0.42-1.61-0.78
Year Ago EPS-0.8-1.63-3.83-2.3
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts771010
Avg. Estimate68.21M70.95M281.22M381.52M
Low Estimate64M65.8M272.88M341M
High Estimate72.83M75M288M406.96M
Year Ago Sales58.13M56.78M234.04M281.22M
Sales Growth (year/est)17.30%25.00%20.20%35.70%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-0.78-0.85-0.72-0.75
EPS Actual-0.8-1.63-0.62-0.58
Difference-0.02-0.780.10.17
Surprise %-2.60%-91.80%13.90%22.70%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.51-0.49-2.3-1.06
7 Days Ago-0.51-0.49-2.3-1.06
30 Days Ago-0.51-0.49-2.3-1.06
60 Days Ago-0.51-0.49-2.3-1.06
90 Days Ago-0.47-0.47-1.9-0.91
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRVNCIndustrySector(s)S&P 500
Current Qtr.36.30%N/AN/AN/A
Next Qtr.69.90%N/AN/AN/A
Current Year39.90%N/AN/AN/A
Next Year53.90%N/AN/AN/A
Next 5 Years (per annum)11.60%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A